Background: |
Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). Required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains. Important role in chondroitin chain biosynthesis in cartilage. |
Applications: |
IHC |
Name of antibody: |
CSGALNACT1 |
Immunogen: |
Synthesized peptide derived from internal of human CSGALNACT1. |
Full name: |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
Synonyms: |
ChGn; CSGalNAcT-1; beta4GalNAcT |
SwissProt: |
Q8TDX6 |
IHC positive control: |
Human breast carcinoma tissue |
IHC Recommend dilution: |
50-100 |